KetoAir™ Mobile Application Launches in Apple App Store

KetoAir™ Mobile Application also Available in the Google Play Store

FREEHOLD, N.J., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of innovative precision diagnostics and provider of clinical laboratory services, today announced the launch of the KetoAir™ mobile application in the Apple App store. The KetoAir™ mobile application is also available in the Google Play store.

In April 2023, Avalon announced that it has partnered with Qi Diagnostics to exclusively distribute the KetoAir™ in North America, South America, the U.K. and the EU. KetoAir™ functions as a companion diagnostic and monitoring device, combined with an artificial intelligence (AI) nutritionist consultation for ketogenic dietary management (United States FDA registration number: 3026284320).

“We are excited to launch the KetoAir app on the Apple App store. KetoAir™ is the first breathalyzer on the market that uses an AI nutritionist bundled with a nanosensor-based breathalyzer for ketogenic health management. Apple owners can now easily download the app from the Apple App store, pair your KetoAir™ Breathalyzer device via Bluetooth, and log in to track your ketosis record,” commented David Jin, M.D., Ph.D., President and Chief Executive Officer of Avalon. “The KetoAir™ breathalyzer device is the perfect tool for health and wellness conscious individuals who are looking to optimize their ketosis state and body fat burning rate. The pocket-sized breathalyzer provides accurate and instant results in a single blow, giving the user the ability to monitor how different foods and activities affect their ketone level. Additionally, the AI nutritionist on the app will analyze the dietary plan and acts as a companion consultant by providing personalized nutritional and exercise recommendations to help achieve the user’s ultimate health goal.”

About Avalon GloboCare Corp.

Avalon GloboCare Corp. (NASDAQ: ALBT) is a commercial stage company dedicated to developing and delivering innovative, transformative, precision diagnostics and clinical laboratory services. Avalon is establishing a leading role in the innovation of diagnostic testing, utilizing proprietary technology to deliver precise, genetics-driven results. The Company also provides laboratory services, offering a broad portfolio of diagnostic tests including drug testing, toxicology, and a broad array of test services, from general bloodwork to anatomic pathology, and urine toxicology. For more information about Avalon GloboCare, please visit www.avalon-globocare.com.